These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 28209529)
1. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause. Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529 [TBL] [Abstract][Full Text] [Related]
2. Physical Activity, BMI, and Risk of Fecal Incontinence in the Nurses' Health Study. Staller K; Song M; Grodstein F; Matthews CA; Whitehead WE; Kuo B; Chan AT; Townsend MK Clin Transl Gastroenterol; 2018 Oct; 9(10):200. PubMed ID: 30356052 [TBL] [Abstract][Full Text] [Related]
3. Increased Long-term Dietary Fiber Intake Is Associated With a Decreased Risk of Fecal Incontinence in Older Women. Staller K; Song M; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT Gastroenterology; 2018 Sep; 155(3):661-667.e1. PubMed ID: 29758215 [TBL] [Abstract][Full Text] [Related]
4. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study. Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415 [TBL] [Abstract][Full Text] [Related]
5. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Khalili H; Higuchi LM; Ananthakrishnan AN; Manson JE; Feskanich D; Richter JM; Fuchs CS; Chan AT Gastroenterology; 2012 Nov; 143(5):1199-1206. PubMed ID: 22841783 [TBL] [Abstract][Full Text] [Related]
6. Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort. Engel P; Fabre A; Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F Am J Epidemiol; 2011 Jul; 174(1):12-21. PubMed ID: 21555715 [TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395 [TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786 [TBL] [Abstract][Full Text] [Related]
9. Effect of menopausal hormonal therapy on cardiovascular risks in Korean postmenopausal women: A nationwide cohort study. Yuk JS; Kim GS; Byun YS; Yang SW; Kim MH; Yoon SH; Seo YS; Kim BG BJOG; 2024 Aug; 131(9):1306-1317. PubMed ID: 38465460 [TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone therapy and incident urinary incontinence in middle-aged women. Townsend MK; Curhan GC; Resnick NM; Grodstein F Am J Obstet Gynecol; 2009 Jan; 200(1):86.e1-5. PubMed ID: 19019333 [TBL] [Abstract][Full Text] [Related]
11. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study. Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928 [TBL] [Abstract][Full Text] [Related]
12. Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study. Burke KE; Ananthakrishnan AN; Lochhead P; Liu PH; Olen O; Ludvigsson JF; Richter JM; Tworoger SS; Chan AT; Khalili H Gastroenterology; 2018 Dec; 155(6):1764-1775.e2. PubMed ID: 30144433 [TBL] [Abstract][Full Text] [Related]
13. Is breast cancer risk the same for all progestogens? Stute P Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. Beral V; Reeves G; Bull D; Green J; J Natl Cancer Inst; 2011 Feb; 103(4):296-305. PubMed ID: 21278356 [TBL] [Abstract][Full Text] [Related]
15. Menopause and postmenopausal hormone therapy and risk of hearing loss. Curhan SG; Eliassen AH; Eavey RD; Wang M; Lin BM; Curhan GC Menopause; 2017 Sep; 24(9):1049-1056. PubMed ID: 28486246 [TBL] [Abstract][Full Text] [Related]
16. Menopausal Hormone Therapy and Risk of Diverticulitis. Jovani M; Ma W; Joshi AD; Liu PH; Nguyen LH; Cao Y; Tam I; Wu K; Giovannucci EL; Chan AT; Strate LL Am J Gastroenterol; 2019 Feb; 114(2):315-321. PubMed ID: 30730324 [TBL] [Abstract][Full Text] [Related]
17. Reproductive history and risk of colorectal cancer in postmenopausal women. Zervoudakis A; Strickler HD; Park Y; Xue X; Hollenbeck A; Schatzkin A; Gunter MJ J Natl Cancer Inst; 2011 May; 103(10):826-34. PubMed ID: 21447807 [TBL] [Abstract][Full Text] [Related]
18. Body fat distribution, menopausal hormone therapy and incident type 2 diabetes in postmenopausal women of the MESA study. Ebong IA; Watson KE; Hairston KG; Carnethon MR; Ouyang P; Szklo M; Bertoni AG Maturitas; 2016 Sep; 91():147-52. PubMed ID: 27451334 [TBL] [Abstract][Full Text] [Related]
19. Endometrial cancer risk with menopausal hormone therapy: Health Insurance Database in South Korea-based cohort study. Yuk JS Int J Gynaecol Obstet; 2023 Aug; 162(2):502-513. PubMed ID: 36964935 [TBL] [Abstract][Full Text] [Related]
20. [Menopause and risk of thromboembolic events. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]. Hugon-Rodin J; Perol S; Plu-Bureau G Gynecol Obstet Fertil Senol; 2021 May; 49(5):455-461. PubMed ID: 33757918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]